Ravnborg, A. B., Hvas, C. L., Agnholt, J., Dahlerup, J. F., Vind, I., Till, A., Rosenstiel, P.
& Höllsberg, P. (2009).
Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
Clinical and Experimental Immunology,
155, 487-95.
Baunwall, S. M. D., Terveer, E. M.
, Dahlerup, J. F., Erikstrup, C., Arkkila, P., Vehreschild, M. JGT., Ianiro, G., Gasbarrini, A., Sokol, H., Kump, P. K., Satokari, R., De Looze, D., Vermeire, S., Nakov, R., Brezina, J., Helms, M., Kjeldsen, J., Rode, A. A., Kousgaard, S. J.
... Hvas, C. L. (2021).
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.
The Lancet Regional Health - Europe,
9, Article 100181.
https://doi.org/10.1016/j.lanepe.2021.100181
Cold, F.
, Baunwall, S. M. D., Dahlerup, J. F., Petersen, A. M.
, Hvas, C. L. & Hansen, L. H. (2021).
Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy.
Therapeutic Advances in Gastroenterology,
14.
https://doi.org/10.1177/17562848211041004Keller, J. J., Vehreschild, M. JGT.
, Hvas, C. L., Jørgensen, S. MD., Kupciskas, J., Link, A., Mulder, C. JJ., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P. (2019).
Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug.
United European Gastroenterology Journal,
7(10), 1408-1410.
https://doi.org/10.1177/2050640619887579Ianiro, G., Mullish, B. H.
, Hvas, C. L., Segal, J. P., Kuijper, E. J., Costello, S. P., Kelly, C. R., Allegretti, J. R., Fischer, M., Iqbal, T. H., Satokari, R., Kao, D., Prehn, J. V., Ng, S. C., Bibbò, S.
, Baunwall, S. M. D., Quraishi, M. N., Sokol, H., Zhang, F. ... Cammarota, G. (2021).
SARS-CoV-2 vaccines and donor recruitment for FMT.
The Lancet Gastroenterology and Hepatology,
6(4), 264-266.
https://doi.org/10.1016/S2468-1253(21)00032-7Hvas, C. L., Farrer, K., Blackett, B., Lloyd, H., Paine, P. & Lal, S. (2018).
Reduced 30-day gastrostomy placement mortality following the introduction of a multidisciplinary nutrition support team: a cohort study.
Journal of Human Nutrition and Dietetics,
31(3), 413-421.
https://doi.org/10.1111/jhn.12520
Dahl Jørgensen, S. M., Erikstrup, C., Dinh, K. M., Lemming, L. E., Dahlerup, J. F. & Hvas, C. L. (2018).
Recruitment of feces donors among blood donors: Results from an observational cohort study.
Gut Microbes,
9(6), 540-550.
https://doi.org/10.1080/19490976.2018.1458179
Paaske, S. E., Baumwall, S. M. D., Rubak, T., Birn, F. H., Rågård, N., Kelsen, J., Hansen, M. M., Svenningsen, L., Krarup, A. L., Fernis, C. M. C.
, Neumann, A., Lødrup, A. B., Glerup, H., Vinter-Jensen, L., Helms, M.
, Erikstrup, L. T., Grosen, A. K., Mikkelsen, S., Erikstrup, C. ... Hvas, C. L. (2025).
Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection.
Clinical Gastroenterology and Hepatology,
23(4), 602-611.e8.
https://doi.org/10.1016/j.cgh.2024.05.038
Hvas, C. L., Ott, P., Paine, P., Lal, S.
, Jørgensen, S. P. & Dahlerup, J. F. (2018).
Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature.
World Journal of Gastroenterology,
24(21), 2320-2326.
https://doi.org/10.3748/wjg.v24.i21.2320
Ianiro, G., Mullish, B. H., Iqbal, T. H., Terveer, E. M.
, Baunwall, S. M. D., Link, A., Sokol, H., Kupcinskas, J., Masucci, L., Sanguinetti, M., Vehreschild, M. J. G. T.
, Hvas, C. L., Keller, J. J., Gasbarrini, A., Kujiper, E. J. & Cammarota, G. (2022).
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel.
The Lancet Gastroenterology and Hepatology,
7(11), 979-980.
https://doi.org/10.1016/S2468-1253(22)00305-3Rubak, T., Baunwall, S. M. D., Gregersen, M., Hansen, T. K., Rosenbæk, J. B., Erikstrup, L. T., Hvas, C. L. & Damsgaard, E. M. S. (2023).
Frailty level at discharge predicts mortality in older patients with Clostridioides difficile more accurately than age or disease severity.
European Geriatric Medicine,
14(3), 583-593.
https://doi.org/10.1007/s41999-023-00772-3
Hvas, C. L., Jørgensen, S. M. D., Jørgensen, S. P., Storgaard, M., Lemming, L., Hansen, M. M., Erikstrup, C. & Dahlerup, J. F. (2019).
Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
Gastroenterology,
156(5), 1324-1332.e3.
https://doi.org/10.1053/j.gastro.2018.12.019
Baunwall, S. M. D., Lee, M. M.
, Eriksen, M. K., Mullish, B. H., Marchesi, J. R.
, Dahlerup, J. F. & Hvas, C. L. (2020).
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis.
EClinicalMedicine,
29-30, Article 100642.
https://doi.org/10.1016/j.eclinm.2020.100642
Dahl Baunwall, S. M., Andreasen, S. E., Hansen, M. M., Kelsen, J., Høyer, K., Rågård, N., Eriksen, L. L., Støy, S., Rubak, T. M. M., Damsgaard, E. M. S., Mikkelsen, S., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L. (2022).
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial.
The Lancet Gastroenterology and Hepatology,
7(12), 1083-1091.
https://doi.org/10.1016/S2468-1253(22)00276-X
Bahl, M. I.
, Jørgensen, S. M. D., Skriver, A. H., Larsen, N. A.
, Wang, M., Licht, T. R.
, Dahlerup, J. F. & Hvas, C. L. (2020).
Faecal microbiota transplantation for eradication of co-infection with Clostridioides difficile and extensively drug-resistant KPC-producing Klebsiella pneumoniae.
Scandinavian Journal of Gastroenterology,
55(5), 626-630.
https://doi.org/10.1080/00365521.2020.1753806
